Federated Hermes, Inc. Haemonetics Corp Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,990 shares of HAE stock, worth $275,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,990

Previous 33,348 88.04%

Holding current value

$275,509

Previous $2.76 Million 88.4%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $2.13 Million - $2.69 Million	-29,358 Reduced 88.04%	3,990 $320,000
Q2 2024 Aug 08, 2024	SELL	$81.24 - $97.37 $207,893 - $249,169	-2,559 Reduced 7.13%	33,348 $2.76 Million
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $226,899 - $271,839	-3,185 Reduced 8.15%	35,907 $3.06 Million
Q4 2023 Jan 31, 2024	SELL	$80.59 - $92.61 $152,073 - $174,755	-1,887 Reduced 4.6%	39,092 $3.34 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $73,973 - $83,767	-896 Reduced 2.14%	40,979 $3.67 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $2.78 Million - $3.08 Million	34,389 Added 459.38%	41,875 $3.57 Million
Q1 2023 May 08, 2023	SELL	$72.75 - $90.6 $26,481 - $32,978	-364 Reduced 4.64%	7,486 $619,000
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $119,193 - $139,029	-1,614 Reduced 17.05%	7,850 $617,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $115,649 - $143,711	-1,827 Reduced 16.18%	9,464 $700,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $22.2 Million - $29.8 Million	-451,295 Reduced 97.56%	11,291 $736,000
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $14 Million - $20.2 Million	320,184 Added 224.85%	462,586 $29.2 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $6.56 Million - $9.88 Million	132,391 Added 1322.46%	142,402 $7.55 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $223,430 - $273,818	3,879 Added 63.26%	10,011 $707,000
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $205,115 - $469,379	-3,959 Reduced 39.23%	6,132 $409,000
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $42,516 - $53,420	-383 Reduced 3.66%	10,091 $1.12 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $3.94 Million - $5.33 Million	-44,410 Reduced 80.92%	10,474 $1.24 Million
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $1.64 Million - $2.03 Million	-21,670 Reduced 28.31%	54,884 $4.79 Million
Q2 2020 Aug 13, 2020	BUY	$84.96 - $118.91 $5.17 Million - $7.24 Million	60,888 Added 388.66%	76,554 $6.86 Million
Q1 2020 May 13, 2020	SELL	$74.34 - $121.82 $5.96 Million - $9.77 Million	-80,169 Reduced 83.65%	15,666 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $1.12 Million - $1.27 Million	9,820 Added 11.42%	95,835 $11 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $8.11 Million - $9.59 Million	69,200 Added 411.54%	86,015 $10.9 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $462,484 - $680,883	-5,658 Reduced 25.18%	16,815 $2.02 Million
Q1 2019 May 10, 2019	SELL	$83.25 - $102.12 $8.76 Million - $10.7 Million	-105,219 Reduced 82.4%	22,473 $1.97 Million
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $3.36 Million - $4.32 Million	-37,042 Reduced 22.49%	127,692 $12.8 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.09 Million - $1.38 Million	-12,085 Reduced 6.83%	164,734 $18.9 Million
Q2 2018 Aug 10, 2018	BUY	$71.53 - $95.75 $2.26 Million - $3.02 Million	31,551 Added 21.72%	176,819 $15.9 Million
Q1 2018 May 09, 2018	BUY	$60.72 - $74.41 $8.75 Million - $10.7 Million	144,102 Added 12358.66%	145,268 $10.6 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $1,393 - $1,828	-31 Reduced 2.59%	1,166 $0
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $48,334 - $53,709	1,197	1,197 $54,000

Others Institutions Holding HAE

# of Institutions

334

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Haemonetics Corp Transaction History